Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3041847 | 0.81 | ALDH1A1 (0.49) | HPGDKMT2ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL11495787 | 0.76 | ALDH1A1 (0.46) | KMT2ASMN1; SMN2ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL3054334 | 0.74 | MEN1 (0.65) | HPGDKMT2ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL5286578 | 0.72 | HPGD (0.49) | HPGDKMT2ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL3045866 | 0.72 | LMNA (0.45) | HPGDSMN1; SMN2ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL4619856 | 0.71 | NPC1 (0.56) | HPGDKMT2ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL4485273 | 0.71 | ALDH1A1 (0.41) | HPGDKMT2ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL2550650 | 0.70 | NPC1 (0.54) | HPGDKMT2ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL23094223 | 0.69 | L3MBTL1 (1.00) | HPGDKMT2ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL11217076 | 0.69 | NPC1 (0.55) | HPGDKMT2ASMN1; SMN2ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8647878-B2 | Highly refractive immersion liquids and their use | CARL ZEISS AG (DE) | 2014-02-11 | — | — | US | disclosed |
| US-20100212547-A1 | Highly Refractive Immersion Liquids And Their Use | CARL ZEISS AG (DE) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100212547-A1 | Highly Refractive Immersion Liquids And Their Use | NR4A3, NR2E3, NR4A1 | HPGD 3875/4885KMT2A 3367/4885SMN1; SMN2 3042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.